SHMT2 and familial pancreatic carcinoma: Although the L474F site of SHMT1 was not confirmed to have a direct protective effect against pancreatic cancer, the study suggested that the loss of SHMT1 nuclear localization may be compensated by SHMT2 through metabolic mechanisms, thereby playing a role in the tumor environment (Chittiboyina et al., 2018).